rs146597836
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001282225.2(ADA2):c.927G>A(p.Met309Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00155 in 1,614,082 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001282225.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA2 | NM_001282225.2 | c.927G>A | p.Met309Ile | missense_variant | 6/10 | ENST00000399837.8 | NP_001269154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA2 | ENST00000399837.8 | c.927G>A | p.Met309Ile | missense_variant | 6/10 | 1 | NM_001282225.2 | ENSP00000382731.2 |
Frequencies
GnomAD3 genomes AF: 0.00159 AC: 242AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00175 AC: 441AN: 251468Hom.: 1 AF XY: 0.00185 AC XY: 252AN XY: 135906
GnomAD4 exome AF: 0.00154 AC: 2255AN: 1461760Hom.: 4 Cov.: 30 AF XY: 0.00164 AC XY: 1196AN XY: 727200
GnomAD4 genome AF: 0.00159 AC: 242AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.00152 AC XY: 113AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | ADA2: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jul 19, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 19, 2018 | The p.Met309Ile variant in ADA2 is classified as benign because of its high frequency of 0.61% in Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs146597836). This variant is present in ClinVar (variant ID 361951). Computational prediction tools and conservation analysis suggest that the p.Met309Ile variant may not impact the protein. ACMG/AMP criteria applied: BA1, BP4. - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 16, 2022 | - - |
Behcet disease Pathogenic:1
Pathogenic, no assertion criteria provided | case-control | Department of Immunology, Hospital Universitario Virgen del Rocio | Jan 13, 2017 | - - |
Vasculitis due to ADA2 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Autoinflammatory syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 17, 2022 | - - |
ADA2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 05, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at